ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04080	Neuroactive ligand-receptor interaction	49/161	423/7206	5.07422604314e-23
ko04724	Glutamatergic synapse	25/161	152/7206	2.09080482504e-15
ko05033	Nicotine addiction	14/161	56/7206	1.12942069823e-11
ko04728	Dopaminergic synapse	20/161	185/7206	3.91700237591e-09
ko04727	GABAergic synapse	15/161	110/7206	1.68564875045e-08
ko05014	Amyotrophic lateral sclerosis (ALS)	12/161	74/7206	6.80106114424e-08
ko04742	Taste transduction	11/161	61/7206	7.84336587591e-08
ko04024	cAMP signaling pathway	22/161	279/7206	2.06681694232e-07
ko04723	Retrograde endocannabinoid signaling	17/161	175/7206	3.00623419418e-07
ko04713	Circadian entrainment	14/161	136/7206	1.76395047422e-06
ko04720	Long-term potentiation	11/161	99/7206	1.13725732352e-05
ko04261	Adrenergic signaling in cardiomyocytes	16/161	205/7206	1.21450481553e-05
ko05030	Cocaine addiction	9/161	73/7206	3.16702410546e-05
ko05031	Amphetamine addiction	10/161	91/7206	3.17686126814e-05
ko04726	Serotonergic synapse	12/161	137/7206	5.1088267777e-05
ko04514	Cell adhesion molecules (CAMs)	11/161	130/7206	0.000144455464901
ko05032	Morphine addiction	10/161	110/7206	0.000161101114492
ko04015	Rap1 signaling pathway	15/161	278/7206	0.00132804516944
ko04721	Synaptic vesicle cycle	7/161	80/7206	0.00197354223864
ko04020	Calcium signaling pathway	14/161	265/7206	0.00233850163383
ko04921	Oxytocin signaling pathway	12/161	209/7206	0.00241766834727
ko04725	Cholinergic synapse	10/161	160/7206	0.00300863362428
ko04071	Sphingolipid signaling pathway	10/161	162/7206	0.00329131565813
ko00430	Taurine and hypotaurine metabolism	3/161	14/7206	0.00332432231579
ko02024	Quorum sensing	3/161	15/7206	0.00408781358947
ko04010	MAPK signaling pathway	15/161	321/7206	0.00587142855192
ko04014	Ras signaling pathway	13/161	279/7206	0.0110373403658
ko04972	Pancreatic secretion	7/161	111/7206	0.0118918314
ko05414	Dilated cardiomyopathy	7/161	112/7206	0.0124533192728
ko04072	Phospholipase D signaling pathway	10/161	197/7206	0.0126135250777
ko04911	Insulin secretion	7/161	117/7206	0.0155509451159
ko04970	Salivary secretion	6/161	95/7206	0.0192394673808
ko00650	Butanoate metabolism	3/161	26/7206	0.0195265031526
ko05203	Viral carcinogenesis	1/161	277/7206	0.0217196223144
ko04260	Cardiac muscle contraction	6/161	98/7206	0.0220746907876
ko04540	Gap junction	7/161	128/7206	0.0242266647981
ko04022	cGMP-PKG signaling pathway	10/161	216/7206	0.0296343178353
ko04925	Aldosterone synthesis and secretion	6/161	105/7206	0.0297561048726
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	5/161	79/7206	0.0313649750577
ko04940	Type I diabetes mellitus	3/161	32/7206	0.0338133812004
ko00604	Glycosphingolipid biosynthesis - ganglio series	2/161	14/7206	0.0378590974122
ko04961	Endocrine and other factor-regulated calcium reabsorption	4/161	59/7206	0.0422953578154
ko00410	beta-Alanine metabolism	3/161	35/7206	0.0425211984949
ko05034	Alcoholism	10/161	238/7206	0.0444118988799